Dr. Reva Basho is the Senior Director of the Women’s Cancer Program at the Ellison Institute. She is a breast medical oncologist and an assistant professor of medicine.
Prior to the Institute, Dr. Basho served as the Co-Director of the Women’s Cancer Research Program at Cedars-Sinai. She received her undergraduate training at Rice University and her medical degree from Baylor College of Medicine. She completed her internal Medicine residency at UCLA Medical Center and her Hematology and Oncology fellowship at MD Anderson Cancer Center.
Alongside her clinical practice, Dr. Basho is a respected and nationally-recognized clinical investigator. Her research focuses on the development of novel therapies for the treatment of high-risk breast cancers. Her specific interests include targeting the PI3K pathway and the development of novel immune therapies. She has served as the PI of numerous clinical trials and is currently leading a sub-study of the National Cancer Institute’s ComboMATCH trial.
Dr. Basho has authored more than 50 research articles, book chapters, and abstracts. She is active in national organizations including the American Society of Clinical Oncology, American Association for Cancer Research, and the Southwest Oncology Group, and she currently serves as a member of the National Cancer Institute’s working group for neoadjuvant clinical endpoints. Dr. Basho is also passionate about mentoring medical students and trainees.